Manos Perros PhD

Dr Manos Perros leads the Infection Innovative Medicines (small molecules) organization and serves as Site Head, Boston R&D. In his role as the iMed Head, Manos is accountable for the Infection delivery from idea to clinical proof-of-concept, from a focused portfolio of programs against serious bacterial infections, respiratory viruses, and neglected infectious diseases (tuberculosis and malaria in particular). Manos's team is based in Boston and Bangalore (India). As the Site Head, Boston, Manos works with the Site Leadership Team to take advantage of the site's contiguities and expertise, coordinate our engagement with the academic, biotech and pharma community, and promote the culture of scientific inquisitiveness, continuous learning and initiative.

Manos is also the executive sponsor for Global Chemistry, and has led the evolution of the organizational and sourcing model in this discipline, including the establishment of the recently announced strategic partnership with Pharmaron (China). A Chemist by training, Manos conducted his PhD work in Belgium, France and Germany, and was Associate in the Biophysics department at Yale from 1993-1995. Prior to joining AstraZeneca, Manos served as Director of the Novartis Institute for Tropical Diseases in Singapore, and prior to that as Vice-President and Chief Scientific Officer, Antivirals at Pfizer.